Screener

Eligibility screening

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia

Sponsored by VA Office of Research and DevelopmentStudy detailsClinicalTrials.gov

4 US sites in CA, MO, NC, WA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.